Experimental Study on Paeoniflorin Inhibiting mTOR Signaling Pathway in Adjuvant Arthritis Rats

MIAO Cheng-gui, XIONG You-yi, QIN Mei-song, CHEN Hao, CHANG Jun

Abstract

To study the effect of paeoniflorin (PF) on mTOR signal in synovial fibroblast-like synoviocytes (FLS) in rats with adjuvant arthritis. Methods AA model rats were prepared by complete Freund's adjuvant injection in foot-plantar, the PF was injected to rats in AA + PF 100 μg/mL group, AA + PF 200 μg/mL group and AA + PF 400 μg/mL group by the tail vein injection at the dose of 0.1 mL/200 g body mass, and the effects of three doses of PF on arthritis scores in AA rats were studied. The modeling rats and control rats were sacrificed at 28 d after modeling, then the synovium was separeated from rat articular, the FLS were cultured. The effect of PF on the expression of mTOR and MMP3 in AA FLS was detected by the real time qPCR. The effect on the cytokine IL-1, IL-6 was detected by ELISA, and the Western blot was used to investigate the role of PF in the mTOR phosphorylation. Furthermore, FLS were transfected with mTOR vectors, and the effect of mTOR overexpression on the PF roles was detected by real time qPCR and ELISA. Results The tail vein injection of PF can significantly reduce the AA rat arthritis score. Compared with AA group, the expression of mTOR in AA+PF 1 μg/mL, AA+PF 2 μg/mL, AA+PF 4 μg/mL was significantly decreased at 48 h after dosing. Compared with AA group, the relative expression of p-mTOR protein in PF 2 μg/mL group was also decreased. Compared with AA group at 48 h after dosing, the levels of IL-1, IL-6 and MMP3 in AA+PF 1 μg/mL, AA+PF 2 μg/mL, AA+PF 4 μg/mL were significantly decreased, respectively. Compared with PF 2 μg/mL group, the relative expression of IL-1, IL-6 and MMP3 in PF 2 μg/mL+mTOR vectors was increased. Conclusion PF can significantly inhibit the pathology of AA rats, and its mechanism may be related to the inhibition of mTOR signal in FLS of AA rats.

 

Keywords: Paeoniflorin, Adjuvant arthritis, Fibroblast-like synovial cells, mTOR signaling

 

Full Text:

PDF


References


GRAMLING A, O’ DELL JR. Initial management of rheumatoid arthritis. Rheum Dis Clin North Am, 2012, 38(2) :311-325.

SOKKAT, RAN NID T, KHAN NA. Disease activity assessment and patient-reported outcomes in patients with early rheumatoid arthritis. Rheum Dis Clin North Am,2012,38(2);299-310.

REYNOLDS A, KOENIG AS, BANANIS E, et al. When is switching warranted among biologic therapies in rheumatoid arthritis, Expert Rev Pharmacoecon Outcomes Res,2012,12

MI АО CG, SHI WJ, XIONG YY, et al. miR-375 regulates the canonical Wnt pathway through FZD8 silencing in arthritis synovial fibroblasts. Immunology Letters, 2015,164 ( 1) : 1-10.

KIM KW, CHO ML. KIM HR. et al. Up-regulation of stromal cell-derived factor 1 ( CXCL12 ) production in

rheumatoid synovial fibroblasts through interactions with T lymphocytes: role of interleukin-17 and CD40L-CD40 interaction. Arthritis Rheum,2007 ,56(4): 1076-1086.

LI С,ZHAO J. SUN L, et al. RANKL downregulates cell surface CXCR6 expression through JAK2/STAT3 signaling pathway during osteoclastogenesis. Biochem Biophys Res Commun,2012,429(3), 156-162.

MOR A, ABRAMSON SB, PILLINGER MH. The fibroblast-like synovial cell in rheumatoid arthritis; a key player in inflammation and joint destruction. Clin Immunol, 2005,115(2): 118-128.


Refbacks

  • There are currently no refbacks.